For people with cancer, a single dose of the magic mushroom–derived drug psilocybin, combined with nine psychotherapy sessions, led to reductions in anxiety and depression that have lasted nearly five years, a study published in the Journal of Psychopharmacology has found. According to lead investigator Gabby Agin-Liebes, a PhD candidate at Palo Alto University in California, the drug facilitates a deep, lasting, meaningful experience that can fundamentally change a person’s mindset and outlook. However, she cautioned, psilocybin should be taken only in a controlled, psychologically safe setting, preferably with counseling from trained mental health practitioners.
Advertisement

Istock
Psychedelic Therapy
This kind of therapy reduces anxiety and depression for people living with cancer.
Advertisement
Advertisement
Comments
Comments